How is this different to the original data which came out in last quarter regarding 60% reduction in mortality yet missing the primary endpoint? I'm hoping for an uptick in the share price for sure BUT not sure this announcement will do much
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-12
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.000(0.00%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.10 | $1.07 | $2.240M | 2.080M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 55786 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 63844 | 6 |
View Market Depth
| Last trade - 11.55am 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |